University of Vermont Cancer Center Member Profile

    Steven Ades, MD

    Professor, Medicine-Hematology Oncology
    Director, Clinical Trial Office

    Full Member
    Academic Interests
    Dr. Ades' research focuses on how to best identify patients who are at the highest risk of developing deep venous clots or pulmonary embolism in the setting of cancer and how to prevent these complications from occurring.

    Postdoctoral Training
    2002-2005..... Masters Degree in Epidemiology and Biostatistics
    2000-2002..... Research Fellow, Tufts University School of Medicine, Boston, MA
    1999-2002..... Hematology/Oncology Fellowship, Tufts University, Boston MA
    1996-1999..... Queens University postgraduate education in Internal Medicine (Kingston General & Hotel Dieu Hospitals, Kingston, Ontario)

    1992-1996..... McGill University, Montreal, Canada; MDCM
    1989-1992..... McGill University, Montreal Canada; BS

    To view more and/or the most recent publications by Steven Ades please visit their biblography here.

    Ng HK, Rogala BG, Ades S, Schwartz JR, Ashikaga T, Vacek P, Holmes CE. Prospective evaluation of drug-drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation. J Oncol Pharm Pract. 2020 Feb 11: 1078155220901569. doi: 10.1177/1078155220901569. PMID: 32046579

    Douce DR, Holmes CE, Cushman M, MacLean C, Ades S, Zakai NA. Risk Factors for Cancer-Associated Venous Thromboembolism: the Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PAAC) Study. J Thromb Haemost. 2019 Aug 18. doi: 10.1111/jth.14614. PMID: 31423717

    Yang MX, Coates RF, Ambaye A, Cortright V, Mitchell JM, Buskey AM, Zubarik R, Liu JG, Ades S, Barry MM. NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors. Biomark Res. 2018 Apr 18,6:15. doi: 10.1186/s40364-018-0129-8. eCollections 2018 PMID: 29713473